In fact, previous results have shown that SVIGF-I treatment decreases liver cirrhosis progression in rat liver [34] and significant improvement in liver function has been observed in patients with alcoholic cirrhosis treated with recombinant IGF-I for 4 months [34]. Here, IGF1 is linked to alcoholic liver cirrhosis.